DOCSLIB.ORG

C-MYC Oncoprotein Dictates Transcriptional Profiles of ATP-Binding Cassette Transporter Genes in Chronic Myelogenous Leukemia Cd34þ Hematopoietic Progenitor Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
C-MYC Oncoprotein Dictates Transcriptional Profiles of ATP-Binding Cassette Transporter Genes in Chronic Myelogenous Leukemia Cd34þ Hematopoietic Progenitor Cells Published OnlineFirst June 21, 2011; DOI: 10.1158/1541-7786.MCR-10-0510 Molecular Cancer Cancer Genes and Genomics Research c-MYC Oncoprotein Dictates Transcriptional Profiles of ATP-Binding Cassette Transporter Genes in Chronic Myelogenous Leukemia CD34þ Hematopoietic Progenitor Cells Antonio Porro1, Nunzio Iraci1, Simona Soverini2, Daniel Diolaiti1, Samuele Gherardi1, Carolina Terragna2, Sandra Durante2, Emanuele Valli1, Thea Kalebic3, Roberto Bernardoni1, Chiara Perrod1, Michelle Haber4, Murray D. Norris4, Michele Baccarani2, Giovanni Martinelli2, and Giovanni Perini1 Abstract Resistance to chemotherapeutic agents remains one of the major impediments to a successful treatment of chronic myeloid leukemia (CML). Misregulation of the activity of a specific group of ATP-binding cassette transporters (ABC) is responsible for reducing the intracellular concentration of drugs in leukemic cells. Moreover, a consistent body of evidence also suggests that ABC transporters play a role in cancer progression beyond the efflux of cytotoxic drugs. Despite a large number of studies that investigated the function of the ABC transporters, little is known about the transcriptional regulation of the ABC genes. Here, we present data showing that the oncoprotein c-MYC is a direct transcriptional regulator of a large set of ABC transporters in CML. Furthermore, molecular analysis carried þ out in CD34 hematopoietic cell precursors of 21 CML patients reveals that the overexpression of ABC transporters þ driven by c-MYC is a peculiar characteristic of the CD34 population in CML and was not found either in the þ population of mononuclear cells from which they had been purified nor in CD34 cells isolated from healthy donors. Finally, we describe how the methylation state of CpG islands may regulate the access of c-MYC to ABCG2 gene promoter, a well-studied gene associated with multidrug resistance in CML, hence, affecting its expression. Taken together, our findings support a model in which c-MYC–driven transcriptional events, combined with epigenetic mechanisms, direct and regulate the expression of ABC genes with possible implications in tumor malignancy and drug efflux in CML. Mol Cancer Res; 9(8); 1054–66. Ó2011 AACR. Introduction accounts for approximately 20% of all leukemias diagnosed þ in adults (1). In CML, the number of CD34 progenitor Chronic myeloid leukemia (CML) is probably the most cells represents a useful diagnostic and prognostic indicator regarding the evolution of this disease (2). Furthermore, in extensively studied human hematopoietic malignancy and þ CML, CD34 hematopoietic progenitors carry the t(9;22) Authors' Affiliations: 1Department of Biology; 2Institute of Hematology "L. (q34;q11) reciprocal chromosomal translocation (chromo- and A. Seragnoli", University of Bologna, Bologna, Italy; 3Novartis Oncol- some Ph), which gives rise to the BCR-ABL proto-oncogene ogy, Clinical Development, New Jersey; and 4Children's Cancer Institute Australia For Medical Research, New South Wales, Sydney, Australia and its constitutively active protein tyrosine kinase product Current address for A. Porro: Ecole Polytechnique Federale de p210/BCR-ABL (3). Currently, treatment of CML is based Lausanne, ISREC-Swiss Institute for Experimental Cancer Research, on the administration of the tyrosine kinase inhibitors, Lausanne, Switzerland. Current address for N. Iraci: Brain Repair which selectively inhibit BCR-ABL tyrosine kinase activity Centre & Cambridge Stem Cell Initiative, University of Cambridge, Cambridge, United Kingdom. Current address for D. Diolaiti: Fred responsible for the pathogenesis of this disease (4). How- Hutchinson Cancer Research Center, Division of Basic Sciences, Seat- ever, patients may experience resistance to tyrosine kinase tle, WA. Current address for T. Kalebic: Millenium, Takeda Company, inhibitors, thus limiting the long-term benefits of the drug. Cambridge, MA. Current address for C. Perrod: Max Delbruck€ Center for Molecular Medicine, Berlin, Germany. The most extensively studied mechanism of drug resistance Note: Supplementary data for this article are available at Molecular Cancer is represented by point mutations in the BCR-ABL kinase Research Online (http://mcr.aacrjournals.org/). domain that impair tyrosine kinase inhibitors binding A. Porro and N. Iraci contributed equally to the work. (reviewed in ref. 5). Nonetheless, mutations have been Corresponding Author: Giovanni Perini, Department of Biology, Univer- found to mediate resistance only in a proportion of resistant sity of Bologna, via F. Selmi 3, 40126 Bologna, Italy. Phone: 39-051-209- patients. Other mechanisms have been invoked but very 467; Fax: 39-051-209-4286; E-mail: [email protected] or Giovanni little is known of their actual role. In this regard, the Martinelli, Molecular Biology Unit, Department of Hematology/Oncology "Seragnoli", University of Bologna, Via Massarenti, 9, 40138 Bologna, Italy. intracellular concentration of tyrosine kinase inhibitors is Phone: 39-051-636-3829; Fax: 39-051-636-4037; E-mail: a critical feature influencing drug efficacy. Successful ther- [email protected] apy of CML is impeded by the development of resistance to doi: 10.1158/1541-7786.MCR-10-0510 a wide spectrum of chemotherapeutic drugs. In a number Ó2011 American Association for Cancer Research. of cancers, a drug-resistant phenotype has been linked to 1054 Mol Cancer Res; 9(8) August 2011 Downloaded from mcr.aacrjournals.org on October 1, 2021. © 2011 American Association for Cancer Research. Published OnlineFirst June 21, 2011; DOI: 10.1158/1541-7786.MCR-10-0510 c-MYC Dictates ABC Expression in CML overexpression of some members of the highly conserved characterized bythepresence ofdoubleminutechromosomes family of transmembrane proteins characterized by an ATP- that contain MYC amplification (19, 20), and a recent study binding cassette (ABC) domain, the so called ABC super- suggests that several oncogenes, involved in myeloid tumor family of transporters (6, 7). Some studies have shown that progression, induce leukemogenesis by activating c-MYC the ABCB1 (PgP/MDR1) and ABCG2 members of this oncoprotein (21). Moreover, in CML, some studies have family are deregulated in imatinib-resistant cell lines and/or shown that BCR-ABL can indirectly activate c-MYC func- patients (8, 9). Less is known on the role of the ABC tion via either the Janus-activated kinase (JAK2) pathway transporters in mediating resistance to the second-generation (22) or the mitogen-activated protein kinase/heterogeneous tyrosine kinase inhibitors (dasatinib and nilotinib) approved nuclear ribonucleoprotein K (MAPK/HNRPK) pathway for imatinib-resistant or intolerant CML patients (10–13). (23) causing increased c-MYC mRNA translation. Further- Moreover, besides their role in conferring drug resistance, a more, c-MYC is located on chromosome 8 (8q24), and wide range of observations and correlative studies indicate trisomy of chromosome 8 is one of the most frequent that high levels of ABC transporters in tumors may determine additional abnormalities detected in CML patients (24). a malignant progression and a more aggressive phenotype Overall,thesefindingspointtoc-MYCasamaindownstream independentlyoftheirroleindrugefflux(reviewed inref.14). actor in leukemias, and in particular in CML pathogenesis, Misregulation of the ABC transporter genes in CML may possibly by modulating transcription of a large set of genes. occur through activity of specific transcription factors whose Recently, we have established that MYCN is responsible function is also altered in this disease. MYC dysregulation is for directing and coordinating the transcription of ABC considered an oncogenic event required for human tumor- genes in neuroblastoma tumors (25). Here, we have inves- igenesis (15–17) and has also been related to the progression tigated whether c-MYC can also orchestrate ABC transcrip- of myeloid leukemias (18). The proto-oncogene c-MYC tion in myeloid leukemias. Importantly, we found that c- þ encodes a basic helix-loop-helix leucine zipper transcription MYC is highly expressed in CD34 progenitor cells from factor that, dimerizing with its partner MAX, controls multi- newly diagnosed chronic phase (CP)-CML patients and that ple cell functions. Patients with myeloid leukemias are often its transcriptional level correlates with that of specific ABC HL-60 Figure 1. c-MYC regulates ABHL-60 transcriptional activity of a large c-MYC group of ABC drug transporter c-MYC genes in HL-60 cells. A, top, β-Actin β-Actin modulation of c-MYC expression DMSO 0 h 24 h 48 h by DMSO in HL-60 cells was shRNA ctrl c-MYC c-MYC monitored at the protein level 10 d 12 d using Western analysis. Bottom, cluster 3 (28) was used to generate an image map showing HL-60 0 h HL-60 24 h HL-60 48 h ABC ABCA2 10 d 12 d expression levels of genes as ABCF2 a function of c-MYC ABCB10 HL-60 shc-MYC HL-60 shc-MYC downregulation mediated by ABCA4 HL-60 shctrl ABCE1 ABCB10 DMSO treatment. Green indicates ABCC1 ABCB9 genes positively regulated by c- ABCB9 ABCC4 ABCC1 MYC, whereas red indicates those ABCF3 negatively regulated. Genes, the ABCB4 ABCA2 expression of which is totally ABCB7 ABCF1 ABCF1 absent in HL-60 cell line, are listed ABCA10 ABCC4 below the cluster. B, top, ABCB8 ABCE1 modulation of c-MYC expression ABCC2 ABCD4 ABCF2 following infection of HL-60 with ABCC6 ABCA10 viruses expressing shRNA ctrl and ABCC10 ABCB2 shRNA c-MYC after 10 and ABCB6 ABCD2 ABCA7 12 days of selection with ABCD1 puromycin. Bottom, cluster
Load more

Recommended publications
  • Whole-Exome Sequencing Identifies Novel Mutations in ABC Transporter
    Liu et al. BMC Pregnancy and Childbirth (2021) 21:110 https://doi.org/10.1186/s12884-021-03595-x RESEARCH ARTICLE Open Access Whole-exome sequencing identifies novel mutations in ABC transporter genes associated with intrahepatic cholestasis of pregnancy disease: a case-control study Xianxian Liu1,2†, Hua Lai1,3†, Siming Xin1,3, Zengming Li1, Xiaoming Zeng1,3, Liju Nie1,3, Zhengyi Liang1,3, Meiling Wu1,3, Jiusheng Zheng1,3* and Yang Zou1,2* Abstract Background: Intrahepatic cholestasis of pregnancy (ICP) can cause premature delivery and stillbirth. Previous studies have reported that mutations in ABC transporter genes strongly influence the transport of bile salts. However, to date, their effects are still largely elusive. Methods: A whole-exome sequencing (WES) approach was used to detect novel variants. Rare novel exonic variants (minor allele frequencies: MAF < 1%) were analyzed. Three web-available tools, namely, SIFT, Mutation Taster and FATHMM, were used to predict protein damage. Protein structure modeling and comparisons between reference and modified protein structures were performed by SWISS-MODEL and Chimera 1.14rc, respectively. Results: We detected a total of 2953 mutations in 44 ABC family transporter genes. When the MAF of loci was controlled in all databases at less than 0.01, 320 mutations were reserved for further analysis. Among these mutations, 42 were novel. We classified these loci into four groups (the damaging, probably damaging, possibly damaging, and neutral groups) according to the prediction results, of which 7 novel possible pathogenic mutations were identified that were located in known functional genes, including ABCB4 (Trp708Ter, Gly527Glu and Lys386Glu), ABCB11 (Gln1194Ter, Gln605Pro and Leu589Met) and ABCC2 (Ser1342Tyr), in the damaging group.
    [Show full text]
  • ABCA7 and Pathogenic Pathways of Alzheimer's Disease
    brain sciences Review ABCA7 and Pathogenic Pathways of Alzheimer’s Disease Tomonori Aikawa, Marie-Louise Holm ID and Takahisa Kanekiyo * Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA; [email protected] (T.A.); [email protected] (M.-L.H.) * Correspondence: [email protected]; Tel.: +1-904-953-2483 Received: 28 December 2017; Accepted: 3 February 2018; Published: 5 February 2018 Abstract: The ATP-binding cassette (ABC) reporter family functions to regulate the homeostasis of phospholipids and cholesterol in the central nervous system, as well as peripheral tissues. ABCA7 belongs to the A subfamily of ABC transporters, which shares 54% sequence identity with ABCA1. While ABCA7 is expressed in a variety of tissues/organs, including the brain, recent genome-wide association studies (GWAS) have identified ABCA7 gene variants as susceptibility loci for late-onset Alzheimer’s disease (AD). More important, subsequent genome sequencing analyses have revealed that premature termination codon mutations in ABCA7 are associated with the increased risk for AD. Alzheimer’s disease is a progressive neurodegenerative disease and the most common cause of dementia, where the accumulation and deposition of amyloid-β (Aβ) peptides cleaved from amyloid precursor protein (APP) in the brain trigger the pathogenic cascade of the disease. In consistence with human genetic studies, increasing evidence has demonstrated that ABCA7 deficiency exacerbates Aβ pathology using in vitro and in vivo models. While ABCA7 has been shown to mediate phagocytic activity in macrophages, ABCA7 is also involved in the microglial Aβ clearance pathway. Furthermore, ABCA7 deficiency results in accelerated Aβ production, likely by facilitating endocytosis and/or processing of APP.
    [Show full text]
  • The Role of ABCA7 in Alzheimer's Disease: Evidence from Genomics
    Acta Neuropathologica https://doi.org/10.1007/s00401-019-01994-1 REVIEW The role of ABCA7 in Alzheimer’s disease: evidence from genomics, transcriptomics and methylomics Arne De Roeck1,2 · Christine Van Broeckhoven1,2 · Kristel Sleegers1,2 Received: 1 February 2019 / Revised: 18 March 2019 / Accepted: 18 March 2019 © The Author(s) 2019 Abstract Genome-wide association studies (GWAS) originally identifed ATP-binding cassette, sub-family A, member 7 (ABCA7), as a novel risk gene of Alzheimer’s disease (AD). Since then, accumulating evidence from in vitro, in vivo, and human-based studies has corroborated and extended this association, promoting ABCA7 as one of the most important risk genes of both early-onset and late-onset AD, harboring both common and rare risk variants with relatively large efect on AD risk. Within this review, we provide a comprehensive assessment of the literature on ABCA7, with a focus on AD-related human -omics studies (e.g. genomics, transcriptomics, and methylomics). In European and African American populations, indirect ABCA7 GWAS associations are explained by expansion of an ABCA7 variable number tandem repeat (VNTR), and a common pre- mature termination codon (PTC) variant, respectively. Rare ABCA7 PTC variants are strongly enriched in AD patients, and some of these have displayed inheritance patterns resembling autosomal dominant AD. In addition, rare missense variants are more frequent in AD patients than healthy controls, whereas a common ABCA7 missense variant may protect from disease. Methylation at several CpG sites in the ABCA7 locus is signifcantly associated with AD. Furthermore, ABCA7 contains many diferent isoforms and ABCA7 splicing has been shown to associate with AD.
    [Show full text]
  • Rare ABCA7 Variants in 2 German Families with Alzheimer Disease
    ARTICLE OPEN ACCESS Rare ABCA7 variants in 2 German families with Alzheimer disease Patrick May, PhD,* Sabrina Pichler, PhD,* Daniela Hartl, PhD, Dheeraj R. Bobbili, MSc, Manuel Mayhaus, PhD, Correspondence Christian Spaniol, PhD, Alexander Kurz, Prof, Rudi Balling, Prof, Jochen G. Schneider, Prof, Dr. Pichler [email protected] and Matthias Riemenschneider, MD, PhD, Prof Neurol Genet 2018;4:e224. doi:10.1212/NXG.0000000000000224 Abstract Objective The aim of this study was to identify variants associated with familial late-onset Alzheimer disease (AD) using whole-genome sequencing. Methods Several families with an autosomal dominant inheritance pattern of AD were analyzed by whole-genome sequencing. Variants were prioritized for rare, likely pathogenic variants in genes already known to be associated with AD and confirmed by Sanger sequencing using standard protocols. Results We identified 2 rare ABCA7 variants (rs143718918 and rs538591288) with varying penetrance in 2 independent German AD families, respectively. The single nucleotide variant (SNV) rs143718918 causes a missense mutation, and the deletion rs538591288 causes a frameshift mutation of ABCA7. Both variants have previously been reported in larger cohorts but with incomplete segregation information. ABCA7 is one of more than 20 AD risk loci that have so far been identified by genome-wide association studies, and both common and rare variants of ABCA7 have previously been described in different populations with higher frequencies in AD cases than in controls and varying penetrance. Furthermore, ABCA7 is known to be involved in several AD-relevant pathways. Conclusions We conclude that both SNVs might contribute to the development of AD in the examined family members.
    [Show full text]
  • ATP-Binding Cassette Transporter ABCA4 and Chemical Isomerization Protect Photoreceptor Cells from the Toxic Accumulation of Excess 11-Cis-Retinal
    ATP-binding cassette transporter ABCA4 and chemical isomerization protect photoreceptor cells from the toxic accumulation of excess 11-cis-retinal Faraz Quazi and Robert S. Molday1 Department of Biochemistry and Molecular Biology, Centre for Macular Research, University of British Columbia, Vancouver, BC, Canada V6T 1Z3 Edited by Jeremy Nathans, Johns Hopkins University, Baltimore, MD, and approved February 25, 2014 (received for review January 15, 2014) The visual cycle is a series of enzyme-catalyzed reactions which disk membranes to facilitate the removal of all-trans-retinal from converts all-trans-retinal to 11-cis-retinal for the regeneration of disk membranes of rod and cone photoreceptor cells following visual pigments in rod and cone photoreceptor cells. Although photoexcitation. Recent studies have confirmed that ABCA4 can essential for vision, 11-cis-retinal like all-trans-retinal is highly toxic flip the all-trans isomer of N-retinylidene-PE and PE from the due to its highly reactive aldehyde group and has to be detoxified lumen to the cytoplasmic leaflet of membranes (6, 10). However, by either reduction to retinol or sequestration within retinal-binding the light-dependent accumulation of lipofuscin and A2E in Abca4 proteins. Previous studies have focused on the role of the ATP-bind- knockout mice has been recently challenged. Boyer et al. (11) have ing cassette transporter ABCA4 associated with Stargardt macular shown that the levels and rates of increase in lipofuscin, including degeneration and retinol dehydrogenases (RDH) in the clearance trans the lipofuscin fluorophore A2E, were similar in dark-reared and of all- -retinal from photoreceptors following photoexcitation.
    [Show full text]
  • Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response
    International Journal of Molecular Sciences Article Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response Viktor Hlaváˇc 1,2 , Radka Václavíková 1,2, Veronika Brynychová 1,2, Renata Koževnikovová 3, Katerina Kopeˇcková 4, David Vrána 5 , Jiˇrí Gatˇek 6 and Pavel Souˇcek 1,2,* 1 Toxicogenomics Unit, National Institute of Public Health, 100 42 Prague, Czech Republic; [email protected] (V.H.); [email protected] (R.V.); [email protected] (V.B.) 2 Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic 3 Department of Oncosurgery, Medicon Services, 140 00 Prague, Czech Republic; [email protected] 4 Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic; [email protected] 5 Department of Oncology, Medical School and Teaching Hospital, Palacky University, 779 00 Olomouc, Czech Republic; [email protected] 6 Department of Surgery, EUC Hospital and University of Tomas Bata in Zlin, 760 01 Zlin, Czech Republic; [email protected] * Correspondence: [email protected]; Tel.: +420-267-082-711 Received: 19 November 2020; Accepted: 11 December 2020; Published: 15 December 2020 Abstract: Breast cancer is the most common cancer in women in the world. The role of germline genetic variability in ATP-binding cassette (ABC) transporters in cancer chemoresistance and prognosis still needs to be elucidated. We used next-generation sequencing to assess associations of germline variants in coding and regulatory sequences of all human ABC genes with response of the patients to the neoadjuvant cytotoxic chemotherapy and disease-free survival (n = 105).
    [Show full text]
  • Influence of ABCA1 and ABCA7 on the Lipid Microenvironment of the Plasma Membrane
    I Influence of ABCA1 and ABCA7 on the lipid microenvironment of the plasma membrane Dissertation zur Erlangung des akademischen Grades doctor rerum naturalium (Dr. rer. nat.) im Fach Biologie eingereicht an der Mathematisch-Naturwissenschaftlichen Fakultät I der Humboldt-Universität zu Berlin von Dottore Magistrale in Biotecnologie Industriali Anna Pia Plazzo geb. 17.10.1981 in San Giovanni Rotondo, Italien Präsident der Humboldt-Universität zu Berlin Prof. Dr. Dr. h.c. Christoph Markschies Dekan der Mathematisch-Naturwissenschaftlichen Fakultät I Prof. Dr. Lutz-Helmut Schön Gutachter: 1. Prof. Dr. Andreas Herrmann 2. Prof. Dr. Thomas Günther-Pomorski 3. Prof. Dr. Thomas Eitinger Tag der mündlichen Prüfung: 12.06.2009 II Alla mia famiglia III Zusammenfassung Der ABC-Transporter ABCA1 ist unmittelbar in die zelluläre Lipidhomeostasie einbezogen, in dem er die Freisetzung von Cholesterol an plasmatische Rezeptoren, wie ApoA-I, vermittelt. Trotz intensiver Untersuchungen ist dieser molekulare Mechanismus nicht verstanden. Verschiedene Studien deuten daraufhin, dass durch die Aktivität von ABCA1 bedingte Veränderungen in der Lipidphase der äußeren Hälfte der Plasmamembran (PM) wichtig für die Freisetzung des Cholesterols sind. In der vorliegenden Arbeit wird die Lipidumgebung von ABCA1 in der PM lebender Säugetierzellen unter Anwendung der Fluoreszenzlebenszeitmikroskopie von fluoreszierenden Lipidsonden untersucht. Es wurde eine breite Verteilung der Fluoreszenzlebenszeiten der Sonden gefunden, die sensitiv gegenüber Veränderungen der lateralen und transversalen Organisation der Lipide ist. Im Einklang mit Studien an riesengroßen unilamellaren Vesikeln und Plasmamembranvesikeln weisen unsere Ergebnisse die Existenz einer größeren Vielfalt submikroskopischer Lipiddomänen auf. Die FLIM-Untersuchungen an ABCA1 exprimierenden HeLa-Zellen weisen eine die Lipidphase destabilisierende Funktion des Transportes aus. Dieses wurde unterstützt durch die Lipidanalyse von Fraktionen der PM.
    [Show full text]
  • Cryo-EM Structure of Lipid Embedded Human ABCA7 at 3.6Å Resolution
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.01.433448; this version posted March 1, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Cryo-EM structure of lipid embedded human ABCA7 at 3.6Å resolution 2 3 Le Thi My Le1†, James R. Thompson1†, Tomonori Aikawa2, Takahisa Kanikeyo2 & Amer Alam1,* 4 5 6 1The Hormel Institute, University of Minnesota, Austin, Minnesota 59912 7 2Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224 8 †These authors contributed equally to this work 9 *Address correspondence to: Amer Alam, PhD, [email protected] 10 11 12 13 14 15 16 17 18 19 20 21 22 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.03.01.433448; this version posted March 1, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 23 Abstract 24 Dysfunction of the ATP Binding Cassette (ABC) transporter ABCA7 alters cellular lipid 25 homeostasis and is linked to Alzheimer’s Disease (AD) pathogenesis through poorly understood 26 mechanisms. Here we determined the cryo-electron microscopy (cryo-EM) structure of human 27 ABCA7 in a lipid environment at 3.6Å resolution that reveals an open conformation, despite bound 28 nucleotides, and bilayer lipids traversing the transmembrane domain (TMD).
    [Show full text]
  • Phosphorylation-Dependent Structural Changes in the N-Terminal Extension of SUR2A NBD1
    Phosphorylation-dependent structural changes in the N-terminal extension of SUR2A NBD1 By Clarissa Rana Sooklal A thesis submitted in conformity with the requirements for the degree of the Master of Science Graduate Department of Chemistry University of Toronto © Copyright by Clarissa Rana Sooklal, 2015 0 Phosphorylation-dependent structural changes in the N-terminal extension of SUR2A NBD1 Master of Science 2015 Clarissa Rana Sooklal Graduate Department of Chemistry University of Toronto Abstract ATP-sensitive potassium (KATP) channels are involved in many biological processes and play an important role in sustaining healthy functioning organs. KATP channels are composed of four copies of a pore-forming Kir6.x protein that is surrounded by four copies of regulatory sulfonylurea receptor (SUR) proteins. SUR proteins are members of the ATP-binding cassette (ABC) superfamily. Nucleotide binding and hydrolysis at the SUR proteins results in channel opening, which is potentiated by SUR protein phosphorylation. The studies conducted during this thesis aimed to understand how phosphorylation of the N-terminal extension (N-tail) of the first nucleotide binding domain (NBD1) of SUR2A alters its structure and influences the N-tail’s interaction with the core NBD1. This biophysical study utilizes nuclear magnetic resonance (NMR) and other biophysical techniques to understand these structural and dynamic changes in N-tail with phosphorylation which will allow us to further understand ATP-binding at NBD1 and control of KATP channel conductance. ii Acknowledgements I would first like to thank to my supervisor, Professor Voula Kanelis for all her support, guidance and direction. She has been my biggest inspiration and my role model throughout my graduate studies.
    [Show full text]
  • Download (1MB)
    MAF aa/Aa/AA aa/Aa/AA GENE POSITION cDNA change Aa change rs ID ExAC MA SIFT POLYPHEN P-VALUE OR cases-ctrls cases ctrls 0.04669- ABCA7 19:1043103 c.G643A p.G215S rs72973581 0.04316 A Tolerated Benign 0/31/301 1/96/579 0.026 0.615 0.07249 0.003012- ABCA7 19:1050996 c.G2629A p.A877T rs74176364 0.01692 A Deleterious Benign 0/2/330 0/16/660 0.072 0.25 0.01183 0.01506- ABCA7 19:1059056 c.G5435A p.R1812H rs114782266 0.01057 A Tolerated Benign 0/10/322 0/11/665 0.162 1.87 0.008136 0.006024- ABCA7 19:1057343 c.G4795A p.V1599M rs117187003 0.003085 A Deleterious Probably damaging 0/4/328 0/3/673 0.226 2.73 0.002219 0.01657- ABCA7 19:1047537 c.A2153C p.N718T rs3752239 0.07028 C Deleterious Benign 0/11/321 0/33/641 0.325 0.665 0.02448 ABCA7 19:1043794 c.G1001A p.R334Q rs147846250 0.001506-0 0.0001995 A Tolerated Benign 0/1/331 0/0/676 0.329 Inf ABCA7 19:1044619 c.C1091G p.P364R rs146982710 0.001506-0 0.0003843 G Tolerated Possibly damaging 0/1/331 0/0/676 0.329 Inf ABCA7 19:1046239 c.C1456G p.P486A rs141428162 0.001506-0 0.0003212 G Deleterious Possibly damaging 0/1/331 0/0/676 0.329 Inf ABCA7 19:1047372 c.G2062A p.A688T rs376686030 0.001506-0 A Tolerated Possibly damaging 0/1/331 0/0/676 0.329 Inf ABCA7 19:1053521 c.C3414G p.S1138R rs1053521 0.001506-0 0.00002865 G Deleterious Possibly damaging 0/1/331 0/0/676 0.329 Inf ABCA7 19:1056372 c.T4460G p.V1487G rs200825702 0.001506-0 0.0001245 G Deleterious Probably damaging 0/1/331 0/0/676 0.329 inf ABCA7 19:1056941 c.G4622A p.C1541Y rs145632609 0.001506-0 0.00004131 A Deleterious Probably damaging 0/1/331
    [Show full text]
  • Factors Involved in the Cisplatin Resistance of KCP‑4 Human Epidermoid Carcinoma Cells
    ONCOLOGY REPORTS 31: 719-726, 2014 Factors involved in the cisplatin resistance of KCP‑4 human epidermoid carcinoma cells SHIGERU OISO1, YUI TAKAYAMA1, RIE NAKAZAKI1, NAOKO MATSUNAGA1, CHIE MOTOOKA1, ASUKA YAMAMURA1, RYUJI IKEDA2, KAZUO NAKAMURA3, YASUO TAKEDA2 and HIROKO KARIYAZONO1 1Department of Pharmaceutical Health Care Sciences, Faculty of Pharmaceutical Sciences, Nagasaki International University, Nagasaki 859-3298; 2Department of Clinical Pharmacy and Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520; 3Department of Biopharmaceutics, Nihon Pharmaceutical University, Saitama 362-0806, Japan Received September 24, 2013; Accepted November 11, 2013 DOI: 10.3892/or.2013.2896 Abstract. KCP-4 is a cisplatin-resistant cell line established Introduction from human epidermoid carcinoma KB-3-1 cells. Although our previous study revealed that one of the mechanisms for Cis-diamminedichloroplatinum II (cisplatin) is one of the cisplatin resistance in KCP-4 cells is the activation of NF-κB, most potent antitumor agents and has clinical activity against its high resistance is considered to be induced by multiple a wide variety of solid tumors, such as ovary, lung, head and mechanisms. In the present study, we explored other factors neck, and bladder cancer (1-5). It is generally accepted that involved in the development of cisplatin resistance in KCP-4 the cytotoxic activity of cisplatin results from its interactions cells. Since it has been reported that an unknown efflux pump with DNA, inhibition of DNA replication and DNA repair, exports cisplatin from KCP-4 cells in an ATP-dependent disturbance of the cell cycle and the beneficial process of manner, we examined 48 types of ATP-binding cassette apoptosis in cancer therapy (6-8).
    [Show full text]
  • Structural Basis of Substrate Recognition and Translocation by Human ABCA4 ✉ Tian Xie 1,2, Zike Zhang1,2, Qi Fang1, Bowen Du1 & Xin Gong 1
    ARTICLE https://doi.org/10.1038/s41467-021-24194-6 OPEN Structural basis of substrate recognition and translocation by human ABCA4 ✉ Tian Xie 1,2, Zike Zhang1,2, Qi Fang1, Bowen Du1 & Xin Gong 1 Human ATP-binding cassette (ABC) subfamily A (ABCA) transporters mediate the transport of various lipid compounds across the membrane. Mutations in human ABCA transporters have been described to cause severe hereditary disorders associated with impaired lipid 1234567890():,; transport. However, little is known about the mechanistic details of substrate recognition and translocation by ABCA transporters. Here, we present three cryo-EM structures of human ABCA4, a retina-specific ABCA transporter, in distinct functional states at resolutions of 3.3–3.4 Å. In the nucleotide-free state, the two transmembrane domains (TMDs) exhibit a lateral-opening conformation, allowing the lateral entry of substrate from the lipid bilayer. The N-retinylidene-phosphatidylethanolamine (NRPE), the physiological lipid substrate of ABCA4, is sandwiched between the two TMDs in the luminal leaflet and is further stabilized by an extended loop from extracellular domain 1. In the ATP-bound state, the two TMDs display a closed conformation, which precludes the substrate binding. Our study provides a molecular basis to understand the mechanism of ABCA4-mediated NRPE recognition and translocation, and suggests a common ‘lateral access and extrusion’ mechanism for ABCA- mediated lipid transport. 1 Department of Biology, Southern University of Science and Technology, Shenzhen,
    [Show full text]